tirzepatide bodybuilding made headlines for weight loss. But that's not why longevity doctors are paying attention. As a dual GIP/GLP-1 receptor agonist, it works on pathways that go far beyond metabolism. The data Tirzepatide Journey: Progress and Support

This playlist explains GLP-1 medications for weight loss in clear, evidence-based terms

GLP-1 stimulates insulin ...

Find out if Wegovy increases blood clot risk, what evidence shows, who may be at risk, and how safe use is ensured under medical supervision.

Clinical Frameworks: Defining Obesity Beyond Body Mass Index (BMI) An important milestone of 2025 was the publication of The Lancet Diabetes & Endocrinology Commission on the Definition and Diagnostic Criteria of Clinical Obesity

However, its use is associated with adverse events that involve to a large extent the cardiovascular and the central nervous system